Recombinant multi-species RPL11 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RPL11 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L5P family of ribosomal proteins. It is located in the cytoplasm. The protein probably associates with the 5S rRNA. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Dec 2010]
The Alternative Names of target: 2010203J19Rik,60S ribosomal protein L11,CLL-associated antigen KW-12,DBA7,GIG34,L11,Large ribosomal subunit protein uL5,RPL11,Rpl11,uL5

Target products collectionGo to RPL11 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP10966-Ag-1/ GM-Tg-hg-IP10966-Ag-2 Human RPL11 protein Human
GM-Tg-rg-IP10966-Ag-1/ GM-Tg-rg-IP10966-Ag-2 Rat RPL11 protein Rat
GM-Tg-mg-IP10966-Ag-1/ GM-Tg-mg-IP10966-Ag-2 Mouse RPL11 protein Mouse
GM-Tg-cynog-IP10966-Ag-1/ GM-Tg-cynog-IP10966-Ag-2 Cynomolgus/Rhesus macaque RPL11 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP10966-Ag-1/ GM-Tg-felg-IP10966-Ag-2 Feline RPL11 protein Feline
GM-Tg-cang-IP10966-Ag-1/ GM-Tg-cang-IP10966-Ag-2 Canine RPL11 protein Canine
GM-Tg-bovg-IP10966-Ag-1/ GM-Tg-bovg-IP10966-Ag-2 Bovine RPL11 protein Bovine
GM-Tg-equg-IP10966-Ag-1/ GM-Tg-equg-IP10966-Ag-2 Equine RPL11 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP10966-Ag-1/ GM-Tg-hg-IP10966-Ag-2; GM-Tg-rg-IP10966-Ag-1/ GM-Tg-rg-IP10966-Ag-2;
GM-Tg-mg-IP10966-Ag-1/ GM-Tg-mg-IP10966-Ag-2; GM-Tg-cynog-IP10966-Ag-1/ GM-Tg-cynog-IP10966-Ag-2;
GM-Tg-felg-IP10966-Ag-1/ GM-Tg-felg-IP10966-Ag-2; GM-Tg-cang-IP10966-Ag-1/ GM-Tg-cang-IP10966-Ag-2;
GM-Tg-bovg-IP10966-Ag-1/ GM-Tg-bovg-IP10966-Ag-2; GM-Tg-equg-IP10966-Ag-1/ GM-Tg-equg-IP10966-Ag-2
Products Name RPL11 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RPL11
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RPL11 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.